The pharmacological inhibition of MDMX by CEP1347 in wild-type p53 retinoblastoma cell lines, which overexpresses MDMX, leads to an increased p53 expression and activation of the p53 pathway [147]. The gene discussed is TP53; the disease is retinoblastoma.